Skip to main content
SpringerLink
Log in

Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The current study was aimed to investigate the clinical value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodule (TN) with inconclusive fine-needle aspiration biopsy (FNAB) results. The current study enrolled 200 patients who showed F-18 FDG incidentaloma and were performed FNAB. The intratumoral heterogeneity of F-18 FDG uptake was represented as the heterogeneity factor (HF), defined as the derivative (dV/dT) of a volume-threshold function for a primary tumor. The diagnostic and predictive values of HF and F-18 FDG PET/CT parameters were evaluated for characterization of inconclusive FNAB results. Among F-18 FDG PET/CT parameters, SUVmax, MTV, and TLG of malignant group were statistically higher than those of Bethesda category of suspicious malignant group. However, HF values were not statistically different between the groups of Bethesda categories (Kruskal–Wallis statistics, 9.924; p = 0.0774). In ROC analysis, when HF > 2.751 was used as cut-off value, the sensitivity and specificity for prediction of malignant TN were 100 % (95 % CI 69.2–100 %) and 60 % (95 % CI 42.1–76.1 %), respectively. The AUC was 0.826 (95 % CI 0.684–0.922) and standard error was 0.0648 (p < 0.0001). In conclusion, the intratumoral heterogeneity of F-18 FDG uptake represented by HF could be a predictor for characterization of TN with inconclusive FNAB results. Additional large population-based prospective studies are needed to validate the diagnostic utility of HF of F-18 FDG PET/CT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. C. Hambleton, E. Kandil, Appropriate and accurate diagnosis of thyroid nodule: a review of thyroid fine-needle aspiration. Int. J. Clin. Exp. Med. 6, 413–422 (2013)

    PubMed Central  PubMed  Google Scholar 

  2. M. Goldfarb, S. Gondek, C. Soloranzo, J.I. Lew, Surgeon-performed ultrasound can predict benignity in thyroid nodules. Surgery 50, 436–441 (2011)

    Article  Google Scholar 

  3. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167–1214 (2009)

    Article  PubMed  Google Scholar 

  4. L. Hegedüs, Clinical practice. The thyroid nodule. N. Engl. J. Med. 351, 1764–1771 (2004)

    Article  PubMed  Google Scholar 

  5. J.R. Porterfield Jr, C.S. Grant, D.S. Dean, G.B. Thompson, D.R. Farley, M.L. Richards, C.C. Reading, J.W. Charboneau, B.K. Vollrath, T.J. Sebo, Reliability of benign fine needle aspiration cytology of large thyroid nodules. Surgery 144, 963–968 (2008)

    Article  PubMed  Google Scholar 

  6. J.B. Ogilvie, E.J. Piatigorsky, O.H. Clark, Current status of fine needle aspiration for thyroid nodules. Adv. Surg. 40, 223–238 (2006)

    Article  PubMed  Google Scholar 

  7. E.S. Cibas, S.Z. Ali, NCI Thyroid FNA State of the Science Conference, The Bethesda system for reporting thyroid cytopathology. Am. J. Clin. Pathol. 132, 658–665 (2009)

    Article  PubMed  Google Scholar 

  8. S. Rorive, N. D’Haene, C. Fossion, I. Delpierre, N. Abarguia, F. Avni, C. Decaestecker, I. Salmon, Ultrasound-guided fine-needle aspiration of thyroid nodules: stratification of malignancy risk using follicular proliferation grading, clinical and ultrasonographic features. Eur. J. Endocrinol. 162, 1107–1115 (2010)

    Article  CAS  PubMed  Google Scholar 

  9. L.J. Layfield, E.S. Cibas, H. Gharib, S.J. Mandel, Thyroid aspiration cytology: current status. CA Cancer J. Clin. 59, 99–110 (2009)

    Article  PubMed  Google Scholar 

  10. G.H. Heppner, Tumor heterogeneity. Cancer Res. 44, 2259–2265 (1984)

    CAS  PubMed  Google Scholar 

  11. R.J. Gillies, P.A. Schornack, T.W. Secomb, N. Raghunand, Causes and effects of heterogeneous perfusion in tumors. Neoplasia 1, 197–207 (1999)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. M.E. Lleonart, P. Martin-Duque, R. Sanchez-Prieto, A. Moreno, S. Cajal, Tumor heterogeneity: morphological, molecular and clinical implications. Histol. Histopathol. 15, 881–889 (2000)

    CAS  PubMed  Google Scholar 

  13. B. Huang, T. Chan, D.L. Kwong, W.K. Chan, P.L. Khong, Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT. AJR Am. J. Roentgenol. 199, 169–174 (2012)

    Article  PubMed  Google Scholar 

  14. F. Tixier, C.C. Le Rest, M. Hatt, N. Albarghach, O. Pradier, Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predict response to concomitant radiochemotherapy in esophageal cancer. J. Nucl. Med. 52, 369–378 (2011)

    Article  PubMed Central  PubMed  Google Scholar 

  15. G.J. Cook, C. Yip, M. Siddique, V. Goh, S. Chicklore, A. Roy, P. Marsden, S. Ahmad, D. Landau, Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J. Nucl. Med. 54, 19–26 (2013)

    Article  PubMed  Google Scholar 

  16. S.H. Son, D.H. Kim, C.M. Hong, C.Y. Kim, S.Y. Jeong, S.W. Lee, J. Lee, B.C. Ahn, Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast. BMC Cancer 14, 585–595 (2014)

    Article  PubMed Central  PubMed  Google Scholar 

  17. E.A. Kidd, P.W. Grigsby, Intratumoral metabolic heterogeneity of cervical cancer. Clin. Cancer Res. 14, 5236–5241 (2008)

    Article  CAS  PubMed  Google Scholar 

  18. T.R. Miller, P.W. Grigsby, Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 53, 353–359 (2002)

    Article  PubMed  Google Scholar 

  19. M. Soret, S.L. Bachrach, I. Buvat, Partial volume effect in PET tumor imaging. J. Nucl. Med. 48, 932–945 (2007)

    Article  PubMed  Google Scholar 

  20. R. Siegel, D. Naishadham, A. Jemal, Cancer statistics, 2012. CA Cancer J. Clin. 62, 10–29 (2012)

    Article  PubMed  Google Scholar 

  21. J.A. Sipos, E.L. Mazzaferri, Thyroid cancer epidemiology and prognostic variables. Clin. Oncol. (R. Coll. Radiol.) 22, 395–404 (2010)

    Article  CAS  Google Scholar 

  22. B. Miller, S. Burkey, G. Lindberg, W.H. Snyder 3rd, F.E. Nwariaku, Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am. J. Surg. 188, 459–462 (2004)

    Article  PubMed  Google Scholar 

  23. G.M. Scabas, G.A. Staerkel, S.E. Shapiro, Fine-needle aspiration of the thyroid and correlation with hispathology in a contemporary series of 240 patients. Am. J. Surg. 186, 702–710 (2003)

    Article  Google Scholar 

  24. S.M. Khoncarly, S.W. Tamarkin, C.R. McHenry, Can ultrasound be used to predict malignancy in patients with a thyroid nodule and an indeterminate fine-needle aspiration biopsy ? Surgery 156, 967–971 (2014)

    Article  PubMed  Google Scholar 

  25. N. Batawil, T. Alkordy, Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules. EJSO 40, 182–186 (2014)

    Article  CAS  PubMed  Google Scholar 

  26. H. Li, K.A. Robinson, B. Anton, I.J. Saldanha, P.W. Ladenson, Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J. Clin. Endocrinol. Metab. 96, E1719–E1726 (2011)

    Article  CAS  PubMed  Google Scholar 

  27. Y.E. Nikiforov, N.P. Ohori, S.P. Hodak, S.E. Carty, S.O. LeBeau, R.L. Ferris, L. Yip, R.R. Seethala, M.E. Tublin, M.T. Stang, C. Coyne, J.T. Johnson, A.F. Stewart, M.N. Nikiforova, Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J. Clin. Endocrinol. Metab. 96, 3390–3397 (2011)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. D. Vriens, E.M. Adang, R.T. Netea-Maier, J.W. Smit, J.H. de Wilt, W.J. Oyen, L.F. de Geus-Oei, Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach. J. Clin. Endocrinol. Metab. 99, 3263–3274 (2014)

    Article  CAS  PubMed  Google Scholar 

  29. A.L. Traugott, F. Dehdashti, K. Trinkaus, M. Cohen, E. Fialkowski, F. Quayle, H. Hussain, R. Davila, L. Ylagan, J.F. Moley, Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18 F-fluorodeoxyglucose positron emission tomography: interim analysis. World J. Surg. 34, 1247–1253 (2010)

    Article  PubMed Central  PubMed  Google Scholar 

  30. D. Deandreis, A. Al Ghuzlan, A. Auperin, P. Vielh, B. Caillou, L. Chami, J. Lumbroso, J.P. Travagli, D. Hartl, E. Baudin, M. Schlumberger, S. Leboulleux, Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid 22, 165–172 (2012)

    Article  CAS  PubMed  Google Scholar 

  31. J.M. Kim, J.S. Ryu, T.Y. Kim, W.B. Kim, G.Y. Kwon, G. Gong, D.H. Moon, S.C. Kim, S.J. Hong, Y.K. Shong, 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J. Clin. Endocrinol. Metab. 92, 1630–1634 (2007)

    Article  CAS  PubMed  Google Scholar 

  32. N.W. Hales, G.A. Krempl, J.E. Medina, Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am. J. Otolaryngol. 29, 113–118 (2008)

    Article  PubMed  Google Scholar 

  33. N. Wang, H. Zhai, Y. Lu, Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for the thyroid nodules with indeterminate fine needle aspiration biopsy? A meta-analysis of the literature. J. Otolaryngol. Head Neck Surg. 42, 38 (2013). doi:10.1186/1916-0216-42-38

    Article  PubMed Central  PubMed  Google Scholar 

  34. D. Vriens, J.H. de Wilt, G.J. van der Wilt, R.T. Netea-Maier, W.J. Oyen, L.F. de Geus-Oei, The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer 117, 4582–4594 (2011)

    Article  PubMed  Google Scholar 

  35. S.H. Kwon, J.K. Yoon, Y.S. An, Y.S. Shin, C.H. Kim, D.H. Lee, K.S. Jo, S.J. Lee, Prognostic significance of the intratumoral heterogeneity of (18) F-FDG uptake in oral cavity cancer. J. Surg. Oncol. 110, 702–706 (2014)

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declared that there is no conflict of interests.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Pusan National University Hospital, 179 Gudeok-Ro, Seo-Gu, Busan, 602-739, Republic of Korea

    Seong-Jang Kim

  2. Biomedical Research Institute, Pusan National University Hospital, Busan, 602-739, Republic of Korea

    Seong-Jang Kim

  3. Department of Radiology, University of Colorado School of Medicine, 12401, 17th Ave, Aurora, CO, 80045, USA

    Samuel Chang

Authors
  1. Seong-Jang Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samuel Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seong-Jang Kim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, SJ., Chang, S. Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results. Endocrine 50, 681–688 (2015). https://doi.org/10.1007/s12020-015-0620-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-015-0620-z

Keywords

Search

Navigation